Pharmaceutical Collaboration

Collaboration is not new in the Pharmaceutical industry as it had started few years back. It involves the association of Pharma industry strategists; decision makers’ etc where great things can be accomplished. Collaborating with Pharma officials not only generates recommendations, guidelines, and best practices, but also fosters new models and pushes the whole sector towards faster progress. And today, faster progress is what we require to deliver more affordable, safer and more effective medicine to patients. Pharmaceutical collaboration improves productivity and efficiency and this approach has been adopted to solve problems in terms of lack of productivity and innovation. Build Right Strategies around Pre-competitive Collaboration Right strategies help to build right strat...

Whatever Glenmark wanted to prove by introducing Zitamed and ZIta, their new anti-diabetes drugs, they’ve definitely topped this season. Mumbai-based Glenmark Pharmaceuticals introduced the two anti-diabetes drugs in aRs 3,000-crore lucrative anti-diabetes market dominated by multinationals The drugmaker, which is locked in a bitter patent infringement battle with US drug firm Merck Sharp and Dohme's (MSD) over these drugs, has managed to rake in Rs 16 crore in just eight months since it launched them, according to data available with All India Organisation of Chemists and Association (AIOCD). In a sort of kickback, Glenmark has priced these drugs at a third of the price of its competitors. Win? We definitely think so. This move may not only rattle the existing market, but also multina...

Pharmaceutical Collaboration

Pharmaceutical Collaboration in Pharma industry

Glenmark Gives India the Push by Topping its Anti-Diabetes Drug